MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 6, 2004; DOI: 10.1124/mol.104.003863


0026-895X/05/6701-241-249$20.00
Mol Pharmacol 67:241-249, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.003863v1
67/1/241    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbier, O.
Right arrow Articles by Staels, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbier, O.
Right arrow Articles by Staels, B.

Hepatic Expression of the UGT1A9 Gene Is Governed by Hepatocyte Nuclear Factor 4{alpha}

Olivier Barbier, Hugo Girard, Yusuke Inoue, Hélène Duez, Lyne Villeneuve, Akihide Kamiya, Jean-Charles Fruchart, Chantal Guillemette, Frank J. Gonzalez, and Bart Staels

UR 545 Institut National de la Santé et de la Recherche Médicale, Département d'Athérosclérose, Institut Pasteur de Lille and the Faculté de Pharmacie, Université de Lille II, Lille, France (O.B., H.D., J.C.F., B.S.); Canada Research Chair in Pharmacogenomics, Oncology and Molecular Endocrinology Research Center, CHUL Research Center and Faculty of Pharmacy, Laval University, Quebec, Canada (H.G., L.V. C.G.); and Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (Y.I., A.K., F.G.)

UDP-glucuronosyltransferase (UGT) enzymes catalyze the glucuronidation reaction, which is a major pathway in the catabolism and elimination of numerous endo- and xenobiotics. Among the UGT enzyme family members, the UGT1A7, UGT1A8, UGT1A9, and UGT1A10 isoforms are issued from a single gene through differential splicing. However, these enzymes display distinct tissue-specific expression patterns. Indeed, UGT1A7, UGT1A8, and UGT1A10 are exclusively expressed in extrahepatic tissues, whereas UGT1A9 transcripts are found at high concentrations in liver. In the present study, we report that the liver-enriched hepatocyte nuclear factor 4 (HNF4)-{alpha} controls the hepatic expression of the UGT1A9 enzyme. Liver-specific disruption of the HNF4{alpha} gene in mice drastically decreases liver UGT1A9 mRNA levels. Furthermore, an HNF4{alpha} response element (HNF4{alpha} RE) was identified in the promoter of human UGT1A9 at position -372 to -360 base pairs by transient transfection, electrophoretic mobility shift assays, and chromatin immunoprecipitation experiments. It is interesting that this response element is absent in the proximal UGT1A7, UGT1A8, and UGT1A10 gene promoters. In conclusion, the present study identifies HNF4{alpha} as a major factor for the control of UGT1A9 hepatic expression and suggests that the absence of UGT1A7, UGT1A8, and UGT1A10 expression in the liver is caused by, at least in part, a few base pair changes in their promoter sequences in the region corresponding to the HNF4{alpha} RE of the UGT1A9 gene.


Received June 13, 2004; accepted September 28, 2004

Address correspondence to: Dr. Bart Staels, Unité INSERM 545, Institut Pasteur de Lille, 1, rue du Pr Calmette, BP 245, 59019 Lille, France. E-mail: bart.staels{at}pasteur-lille.fr




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Ungaro, R. Teperino, P. Mirra, A. Cassese, F. Fiory, G. Perruolo, C. Miele, M. Laakso, P. Formisano, and F. Beguinot
Molecular Cloning and Characterization of the Human PED/PEA-15 Gene Promoter Reveal Antagonistic Regulation by Hepatocyte Nuclear Factor 4{alpha} and Chicken Ovalbumin Upstream Promoter Transcription Factor II
J. Biol. Chem., November 7, 2008; 283(45): 30970 - 30979.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Inoue and M. Negishi
Nuclear Receptor CAR Requires Early Growth Response 1 to Activate the Human Cytochrome P450 2B6 Gene
J. Biol. Chem., April 18, 2008; 283(16): 10425 - 10432.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Ramirez, W. Liu, S. Mirkov, A. A. Desai, P. Chen, S. Das, F. Innocenti, and M. J. Ratain
Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity
Drug Metab. Dispos., December 1, 2007; 35(12): 2149 - 2153.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics